Convalescent plasma in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial
<p><strong>Background:</strong> Many patients with COVID-19 have been treated with plasma containing anti-SARS-CoV-2 antibodies. We aimed to evaluate the safety and efficacy of convalescent plasma therapy in patients admitted to hospital with COVID-19.</p> <p><stron...
প্রধান লেখক: | Horby, PW, Estcourt, L, Peto, L, Emberson, JR, Staplin, N, Spata, E, Cambell, M, Roddick, A, Day, JN, Jeffery, K, Mafham, M, Thwaites, G, Roberts, DJ, Haynes, R, Landray, M, Et al. |
---|---|
বিন্যাস: | Journal article |
ভাষা: | English |
প্রকাশিত: |
Elsevier
2021
|
অনুরূপ উপাদানগুলি
অনুরূপ উপাদানগুলি
-
Tocilizumab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial
অনুযায়ী: Horby, P, অন্যান্য
প্রকাশিত: (2021) -
Aspirin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial
অনুযায়ী: Mafham, M, অন্যান্য
প্রকাশিত: (2021) -
Casirivimab and imdevimab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial
অনুযায়ী: Landray, M, অন্যান্য
প্রকাশিত: (2022) -
Methylprednisolone, intravenous immunoglobulin, tocilizimab or anakinra for children with Paediatric Inflammatory Multisystem Syndrome temporally associated with SARS CoV-2 (PIMS-TS, MIS-C) – report from a randomised, controlled, open-label, platform trial
অনুযায়ী: Haynes, R, অন্যান্য
প্রকাশিত: (2023) -
Dimethyl fumarate in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial
অনুযায়ী: Horby, P, অন্যান্য
প্রকাশিত: (2024)